Establishment of nude mice with complete loss of lymphocytes and NK cells and application for in vivo bio-imaging

In Vivo

Volumn 28, Issue 5, 2014, Pages 779-784

  Kariya, Ryusho ^a   Matsuda, Kouki ^a   Gotoh, Kumiko ^a   Vaeteewoottacharn, Kulthida ^a   Hattori, Shinichiro ^a   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Immunodeficient mice; In vivo imaging; Nude mice; Xeno transplantation

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; BALB/C NUDE MOUSE; BILE DUCT CARCINOMA; BIOIMAGING; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL LOSS; CELL PROLIFERATION; CHOLANGIOCARCINOMA CELL LINE; CONTROLLED STUDY; HISTOLOGY; IMAGING; IN VIVO STUDY; K562 CELL LINE; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; TUMOR VOLUME; XENOTRANSPLANTATION; ANIMAL; BIOPSY; DISEASE MODEL; FLUORESCENCE IMAGING; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; NEOPLASMS; NUDE MOUSE; PATHOLOGY; PROCEDURES; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN; TUMOR CELL LINE; XENOGRAFT;

BIOLOGICAL MARKER;

ANIMALS; BIOLOGICAL MARKERS; BIOPSY; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTES; MICE; MICE, KNOCKOUT; MICE, NUDE; NEOPLASMS; OPTICAL IMAGING; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84918501286     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Flanagan SP: 'Nude', a new hairless gene with pleiotropic effects in the mouse. Genet Res 8: 295-309, 1966.
2. Bellet RE, Danna V, Mastrangelo MJ and Berd D: Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents. J Natl Cancer Inst 63: 1185-1188, 1979.
3. Shimosato Y, Kameya T, Nagai K, Hirohashi S, Koide T, Hayashi H and Nomura T: Transplantation of human tumors in nude mice. J Natl Cancer Inst 56: 1251-1260, 1976.
4. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, Tamaoki N, Kato S and Hotta T: Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169: 204-209, 2002.
5. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A and Manz MG: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107, 2004.
6. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD and Harada M: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106: 1565-1573, 2005.
7. Okada S, Harada H, Ito T, Saito T and Suzu S: Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3(null) mice intrahepatic engrafted with cord blood-derived CD34 (+) cells. Int J Hematol 88: 476-482, 2008.
8. Ono A, Hattori S, Kariya R, Iwanaga S, Taura M, Harada H, Suzu S and Okada S: Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice. J Biomed Biotechnol 2011: 539748, 2011.
9. Phimsen S, Kuwahara K, Nakaya T, Ohta K, Suda T, Rezano A, Kitabatake M, Vaeteewoottacharn K, Okada S, Tone S and Sakaguchi N: Selective cell death of p53-insufficient cancer cells is induced by knockdown of the mRNA export molecule GANP. Apoptosis: an international journal on programmed cell death 17: 679-690, 2012.
10. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM et al: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867, 1992.
11. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirasawa T and Saito T: Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 3: 771-782, 1995.
12. Seubwai W, Wongkham C, Puapairoj A, Okada S and Wongkham S: 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. Cancer 116: 5535-5543, 2010.
13. Troy T, Jekic-McMullen D, Sambucetti L and Rice B: Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol Imaging 3: 9-23, 2004.
14. Kelland LR: Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40: 827-836, 2004.
15. Shultz LD, Ishikawa F and Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130, 2007.
16. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI, Dick JE and Danska JS: Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8: 1313-1323, 2007.
17. Chiu PP, Ivakine E, Mortin-Toth S and Danska JS: Susceptibility to lymphoid neoplasia in immunodeficient strains of nonobese diabetic mice. Cancer Res 62: 5828-5834, 2002.
18. Yui MA and Rothenberg EV: Deranged early T cell development in immunodeficient strains of nonobese diabetic mice. J Immunol 173: 5381-5391, 2004.
19. Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, Umeda S, Leiter E, Hesselton R, Wagar EJ, Leif JH, Kollet O, Lapidot T and Greiner DL: NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J Immunol 164: 2496-2507, 2000.